Bmf is upregulated by PS-341-mediated cell death of glioma cells through JNK phosphorylation
- PMID: 19267218
- DOI: 10.1007/s11033-009-9491-9
Bmf is upregulated by PS-341-mediated cell death of glioma cells through JNK phosphorylation
Abstract
Malignant glioma is resistant to the induction of apoptosis, resulting in a subsequent failure of chemotherapy in clinical treatment strategies. Downregulation of bcl-2 and bcl-xl expression in glioblastoma cells can induce apoptosis. BH3-only proteins, which include Bmf, are essential initiators of stress-induced cell death and apoptosis. Whether PS-341 regulates expression of BH3-only proteins in glioblastoma cells during the procedure of apoptosis is unclear. This study was designed to investigate the effects of PS-341 on glioma cell death and its possible signaling pathway. Our results demonstrate that Bmf is upregulated by PS-341 in A172 and T98G cells, and Bmf has a crucial role in PS-341-mediated cell death. In addition, we found that expression of Bmf is regulated by JNK phosphorylation.
Similar articles
-
Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling.Cancer Sci. 2004 Feb;95(2):176-80. doi: 10.1111/j.1349-7006.2004.tb03200.x. Cancer Sci. 2004. PMID: 14965369 Free PMC article.
-
Potentiation of bortezomib-induced apoptosis by TGF-beta in cultured human Tenon's fibroblasts: contribution of the PI3K/Akt signaling pathway.Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6232-7. doi: 10.1167/iovs.10-5747. Epub 2010 Aug 11. Invest Ophthalmol Vis Sci. 2010. PMID: 20702821
-
Inhibition of heat shock protein response enhances PS-341-mediated glioma cell death.Ann Surg Oncol. 2012 Jul;19 Suppl 3:S421-9. doi: 10.1245/s10434-011-1881-2. Epub 2011 Jul 6. Ann Surg Oncol. 2012. PMID: 21732139
-
The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim.Mol Cancer Ther. 2005 Mar;4(3):443-9. doi: 10.1158/1535-7163.MCT-04-0260. Mol Cancer Ther. 2005. PMID: 15767553
-
PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis.Mol Cancer Ther. 2002 Aug;1(10):841-9. Mol Cancer Ther. 2002. PMID: 12492117
Cited by
-
DNA-dependent protein kinase catalytic subunit mediates T-cell loss in rheumatoid arthritis.EMBO Mol Med. 2010 Oct;2(10):415-27. doi: 10.1002/emmm.201000096. EMBO Mol Med. 2010. PMID: 20878914 Free PMC article.
-
Bortezomib downregulates MGMT expression in T98G glioblastoma cells.Cell Mol Neurobiol. 2013 Apr;33(3):313-8. doi: 10.1007/s10571-013-9910-2. Epub 2013 Jan 20. Cell Mol Neurobiol. 2013. PMID: 23334228 Free PMC article.
-
Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.Oncotarget. 2016 Jan 19;7(3):3520-32. doi: 10.18632/oncotarget.6513. Oncotarget. 2016. PMID: 26657288 Free PMC article.
-
Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner.Invest New Drugs. 2013 Oct;31(5):1169-81. doi: 10.1007/s10637-013-9968-1. Epub 2013 May 5. Invest New Drugs. 2013. PMID: 23645448
-
RBMS2 Chemosensitizes Breast Cancer Cells to Doxorubicin by Regulating BMF Expression.Int J Biol Sci. 2022 Feb 7;18(4):1724-1736. doi: 10.7150/ijbs.66480. eCollection 2022. Int J Biol Sci. 2022. PMID: 35280673 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials